Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VNDA | ALLO | NGNE | ||
| Company | Vanda Pharmaceuticals | Allogene Therapeutics Inc | Neurogene Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.42 | 1.4500 | 20.86 | ||
| High | 6.32 | 1.4600 | 21.87 | ||
| Low | 5.42 | 1.3900 | 20.46 | ||
| Latest | 6.14 | 1.4500 | 20.59 | ||
| Change | +0.75 | +0.0200 | +0.31 | ||
| % Change | +13.91% | +1.40% | +1.53% | ||
| Volume | 2,551,900 | 1,622,900 | 209,700 | ||
| 20-Day Average Volume | 1,046,630 | 2,346,735 | 236,835 | ||
| Previous Close | 5.39 | 1.4300 | 20.28 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.95 | 1.3245 | 22.50 | ||
| 20-Day Raw Stochastic | 91.18% | 81.08% | 10.63% | ||
| 20-Day Relative Strength | 65.88 | 58.11 | 42.47 | ||
| Weighted Alpha | +47.28 | +1.59 | -26.16 | ||
| Today's Opinion | 88% Buy | 56% Buy | 8% Sell | ||
| Previous Opinion | 88% Buy | 56% Buy | 8% Sell | ||
| Last Month's Opinion | 8% Buy | 72% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +22.31% since 12/01/25 | +5.84% since 12/01/25 | +0.54% since 12/01/25 | ||
| Low | 4.89 on 12/03/25 | 1.3000 on 12/02/25 | 19.23 on 12/02/25 | ||
| High | 6.32 on 12/08/25 | 1.5200 on 12/03/25 | 23.00 on 12/04/25 | ||
| 1-Month | |||||
| %Chg | +39.55% since 11/07/25 | +22.88% since 11/07/25 | -23.03% since 11/07/25 | ||
| Low | 4.28 on 11/14/25 | 1.1500 on 11/11/25 | 19.23 on 12/02/25 | ||
| High | 6.32 on 12/08/25 | 1.5200 on 12/03/25 | 32.02 on 11/12/25 | ||
| 3-Month | |||||
| %Chg | +34.95% since 09/08/25 | +27.19% since 09/08/25 | +5.86% since 09/08/25 | ||
| Low | 4.27 on 11/07/25 | 1.0400 on 11/07/25 | 16.77 on 09/23/25 | ||
| High | 6.32 on 12/08/25 | 1.5300 on 10/09/25 | 37.27 on 10/16/25 | ||
| 6-Month | |||||
| %Chg | +33.19% since 06/06/25 | +2.11% since 06/06/25 | -5.68% since 06/06/25 | ||
| Low | 4.14 on 08/07/25 | 0.9842 on 08/07/25 | 14.65 on 07/01/25 | ||
| High | 6.32 on 12/08/25 | 1.6900 on 07/23/25 | 37.27 on 10/16/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 318,533 | 321,364 | 314,137 | ||
| Shares Outstanding, K | 59,097 | 224,730 | 15,490 | ||
| Annual Sales | 198,770,000 | 20,000 | 930,000 | ||
| Annual Net Income | -18,900,000 | -257,590,000 | -75,140,000 | ||
| Last Quarter Sales | 56,260,000 | 0 | 0 | ||
| Last Quarter Net Income | -22,590,000 | -41,400,000 | -20,950,000 | ||
| 60-Month Beta | 0.69 | 0.47 | 1.62 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.38 on 10/29/25 | -0.19 on 11/06/25 | -0.99 on 11/13/25 | ||
| Latest Earnings Date | 10/29/25 | 11/06/25 | 11/17/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||